Lemborexant,
1369764-02-2,
E-2006,
UNII-0K5743G68X,
0K5743G68X,
Cyclopropanecarboxamide, 2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-,
E 2006,
Lemborexant [USAN:INN],
Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-,
Lemborexant(E2006),
Lemborexant; E-2006,
Lemborexant (JAN/USAN/INN),
GTPL9302,
SCHEMBL2116558,
CHEMBL3545367,
MUGXRYIUWFITCP-PGRDOPGGSA-N,
EX-A2337,
BDBM50093793,
AKOS030526457,
ZINC118073503,
DB11951,
SB17434,
compound 34 [PMID: 25953512],
NCGC00488783-01,
HY-16725,
E2006,
J3.610.985H,
D11022,
(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide,
(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide,
(1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide,
CS-4320,